Ultralife Corporation
Jul 28, 2016

Ultralife Corporation Reports Second Quarter Results

NEWARK, N.Y., July 28, 2016 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ:ULBI) reported operating income of $0.5 million on revenue of $20.4 million for the second quarter ended June 26, 2016.  For the second quarter of 2015, the Company reported operating income of $0.8 million on revenue of $19.0 million. 

"Through solid execution of our business model parameters including close control of spending in a challenging economic environment, we delivered profitability for the seventh consecutive quarter and generated positive cash flow," said Michael D. Popielec, Ultralife's President and Chief Executive Officer.  "Despite some economic uncertainties weighing on customer's buying decisions, we still have our sights set on delivering profitable growth for 2016.  Our gross margins and liquidity give us the flexibility to continue to invest in new product development in support of our long-term global diversification strategy."

Second Quarter 2016 Financial Results

Revenue was $20.4 million, an increase of $1.4 million, or 7%, compared to $19.0 million for the second quarter of 2015 reflecting the addition of Accutronics and higher Communications Systems sales.  Battery & Energy Products sales were $15.8 million compared to $16.0 million last year, reflecting the contribution of Accutronics sales which offset the revenue reduction resulting from a large 9-Volt and large metering and toll pass battery orders in the second quarter of 2015.  Communications Systems sales grew 55% to $4.6 million compared to $3.0 million for the same period last year as a result of shipments under the Vehicle Installed Power Enhanced Riflemen Appliqué ("VIPER") Program.

Gross profit was $5.9 million, or 29.0% of revenue, compared to $5.9 million, or 30.9% of revenue, for the same quarter a year ago.  Battery & Energy Products' gross margin was 29.6%, compared to 28.4% last year, an increase of 120 basis points reflecting favorable product mix including the contribution of Accutronics.  Communications Systems' gross margin declined to 26.8% compared to 44.2% for the prior year due to sales mix.        

Operating expenses were $5.4 million compared to $5.0 million last year reflecting the addition of Accutronics and increased spending on new product development in response to a higher level of proposal activity, partially offset by tight control over discretionary spending.  Operating expenses were 26.5% of revenue compared to 26.6% of revenue for the year earlier period.  

Operating income was $0.5 million compared to $0.8 million last year. 

Net income was $0.4 million, or $0.03 per share, compared to a net income of $0.8 million, or $0.05 per share, for the second quarter of 2015.   

Share Repurchase Program

The Company's Share Repurchase Program expired on June 2, 2016.  From the inception of the Program on May 1, 2014 through its expiration, the Company repurchased 2,592,095 shares for an aggregate cost of $10.5 million.

About Ultralife Corporation

Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.

Headquartered in Newark, New York, the Company's business segments include Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit www.ultralifecorporation.com.

Conference Call Information

Ultralife will hold its second quarter earnings conference call today at 10:00 AM ET. To participate in the live call, please dial (800) 915-4836 at least ten minutes before the scheduled start time, identify yourself and ask for the Ultralife call. A live webcast of the conference call will be available to investors in the Events & Presentations section of the Company's website at http://investor.ultralifecorporation.com. For those who cannot listen to the live broadcast, a replay of the webcast will be available shortly after the call at the same location.

This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include:  potential reductions in U.S. military spending, uncertain global economic conditions and acceptance of our new products on a global basis. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company's analysis only as of today's date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances.  Further information on these factors and other factors that could affect Ultralife's financial results is included in Ultralife's Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K. 


ULTRALIFE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Dollars in Thousands)
(Unaudited)
    
 ASSETS
 June 26, December 31, 
  2016   2015  
Current Assets:    
Cash and Cash Equivalents$  3,262  $  14,533  
Trade Accounts Receivable, Net 13,735   11,430  
Inventories 26,553   23,814  
Prepaid Expenses and Other Current Assets 2,440   2,169  
Total Current Assets 45,990   51,946  
     
Property, Equipment and Improvements, Net 8,858   9,038  
Goodwill, Intangibles and Other Assets 28,450   20,538  
Total Assets$  83,298  $  81,522  
     
 LIABILITIES AND SHAREHOLDERS' EQUITY
    
Current Liabilities:   
Accounts Payable$  6,654  $  6,494  
Accrued Compensation and Related Benefits 1,818   2,377  
Accrued Expenses and Other Current Liabilities 2,570   1,976  
Current Portion of Debt 831   -  
Total Current Liabilities 11,873   10,847  
Deferred Income Taxes and Other Non-Current Liabilities 5,569   4,659  
Total Liabilities 17,442   15,506  
     
Shareholders' Equity:    
Common Stock 1,920   1,918  
Capital in Excess of Par Value 177,430     177,007  
Accumulated Deficit (93,306)  (94,051) 
Accumulated Other Comprehensive Loss (1,608)  (907) 
Treasury Stock (18,415)  (17,808) 
Total Ultralife Equity 66,021     66,159  
Non-Controlling Interest (165)  (143) 
Total Shareholders' Equity 65,856   66,016  
     
Total Liabilities and Shareholders' Equity$83,298  $ 81,522  


ULTRALIFE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(In Thousands Except Per Share Amounts)
(Unaudited)
        
 Three Month Periods Ended Six Month Periods Ended
 June 26, June 28, June 26, June 28,
  2016   2015   2016   2015 
Revenues:       
Battery & Energy Products$15,759  $15,972  $32,199  $32,248 
Communication Systems 4,612   2,983   9,005   5,884 
Total Revenues20,371  18,955  $41,204  $38,132 
        
Cost of Products Sold:       
Battery & Energy Products 11,095   11,430   22,318   22,922 
Communication Systems 3,376   1,666   6,581   3,344 
Total Cost of Products Sold 14,471   13,096   28,899   26,266 
        
Gross Profit 5,900   5,859   12,305   11,866 
        
Operating Expenses:       
Research and Development 1,425   1,334   3,081   2,693 
Selling, General and Administrative 3,976   3,708   8,243   7,534 
Total Operating Expenses 5,401   5,042   11,324   10,227 
        
Operating Income  499   817   981   1,639 
        
Other Income (Expense) (24)  28   (137)  (160)
Income Before Income Taxes 475   845   844   1,479  
        
Income Tax Provision 33   71   121   182 
        
Net Income  442   774   723   1,297 
        
Net Loss Attributable to Non-Controlling Interest 4   14   22   24 
        
Net Income Attributable to Ultralife Corporation$446  $788  $745  $1,321 
        
        
Net Income Per Share Attributable to Ultralife Common
    Shareholders — Basic
$.03  $.05  $.05  $.08 
        
Net Income Per Share Attributable to Ultralife Common
    Shareholders — Diluted
$.03  $.05  $.05  $.08 
        
Weighted Average Shares Outstanding — Basic 15,258   16,557   15,290   16,945 
        
Weighted Average Shares Outstanding — Diluted 15,419   16,597   15,545   16,977 


Company Contact:		
Ultralife Corporation		
Philip A. Fain 		
(315) 210-6110		
pfain@ulbi.com		

Investor Relations Contact:
LHA 
Jody Burfening
(212) 838-3777
jburfening@lhai.com